All Time Plastics is an Indian manufacturer of injection-molded plastic houseware and furniture, exporting to 29 countries with Europe contributing 52% of Q1 FY27 revenue, the US 19%, the UK 11%, and domestic India 16%. The company operates roughly 41,000 metric tons of installed capacity across plants at Daman, Silvassa, and Khatalwada, plus a new bamboo board subsidiary. It is the largest exporter of plastic housewares from India, competing against a fragmented unorganized sector; its scale and compliance credentials allow it to serve global retail chains. Gross margin was 39.5% in Q1 FY27, but EBITDA margin slipped to 14.3% from 18.2% a year earlier, due to raw material inflation and the fixed costs of newly commissioned capacity. Historically, EBITDA margins have been 18-19%, indicating the business is capable of high profitability when utilization normalizes.
The economics persist because of long-standing relationships with global retail chains, which require design-to-delivery integration, consistent quality, and compliance. The largest customer has a structured pass-through pricing mechanism with an 8-week rollover lag, which protects margins over time but creates timing volatility. The company also benefits from embedded supply chains and a strong reputation, evidenced by repeat orders from new European customers and a fast-growing US segment that rose from 12% of FY26 revenue to 19% in Q1 FY27. The bamboo initiative is backed by a MoU with the North East Cane and Bamboo Development Council, providing policy support and raw material security, and bamboo product margins are stated to be slightly higher than plastic. However, customer concentration is high (top customer 59%, top customers 78% of revenue), and the moat lies in operational scale and customer relationships rather than proprietary technology.
The inflection is the capacity addition already in motion: 14 new injection moulding machines will add ~1,500 tons in Q4 FY27, and plans exist to order a further ~4,000 tons for arrival by Q4 FY27, taking total capacity to ~52,000 tons. The company targets 75% utilization on the existing 41,000 tons for FY27, up from 64.9% in Q1 FY27, with Q1 polymer volumes at 6,323 tons versus 5,056 tons in Q4 FY26. As volumes scale, fixed costs are absorbed, and management states that at ~80% utilization, the sustainable EBITDA margin is 18-19%. Domestically, the business is targeted to grow 30-35% in FY27, supported by the largest customer's plan to open 20-25 stores in India over two years, each adding INR 40-50 lakhs per month. The bamboo vertical, with 3,000 CBM capacity, is expected to commence commercial production in Q4 FY27. By FY27 year-end, the company should be operating near 75-80% utilization, with a broader product mix and a higher share of US and domestic revenue.
Management's guidance history shows slippage. In Sep-25 they guided 15% revenue CAGR and 4,000 tons of new capacity by H2 FY26; actual 9M FY26 revenue grew 13.4% YoY and Q3 FY26 EBITDA margin was 14.7%, missing the 18-19% target. On the Aug-26 call, they reiterated at least 15-20% revenue growth for FY27 and a 75% utilization target, but gave no quantified EBITDA margin guidance other than expecting improvement. They also reduced the capacity expansion from 52,500 to ~52,000 tons, and only 1,500 tons of new machines are ordered, with 4,000 tons planned but not committed. The balancing sheet is strong (debt/equity 0.14x), so there is no dilution risk, but execution on capacity absorption has been slower than promised, reflected in the guidance monitor downgrade from 77% to 70-75% utilization.
The earnings path is straightforward: if utilization reaches 75% on 41,000 tons, volumes rise roughly 15% from Q1 FY27 annualized, and operating leverage should push EBITDA margin from 14.3% toward 18% by late FY27. A conservative estimate of 15-20% revenue growth and a 16-17% EBITDA margin would yield EBITDA growth of roughly 25-30% from FY26. For this to hold, polymer prices must stabilize (they are currently 40-50% above base due to West Asia conflict) and the pass-through pricing must work without eroding demand. The single most important watchpoint is capacity utilization: if it stays below 70% or if the remaining 4,000 tons order is further delayed, the fixed cost drag will persist and margin recovery will be pushed out. The tension between high gross margin (39.5%) and low EBITDA margin (14.3%) is entirely due to fixed costs and raw material inflation; if revenue scales as guided, margins will normalize. The falsifier is a sustained utilization level below 70% at the end of FY27, which would indicate demand weakness rather than transient disruptions.
companyname: All Time Plastics Limited ticker: ALLTIME sector: Injection-moulded plastic consumerware / houseware manufacturing and export All Time Plastics is an injection-moulded plastic consumerware and furniture manufacturer that sells to global retail chains across 29 countries. Incorporated in 1971, the company describes itself as India's largest exporter of plastic houseware and plastic furniture, and almost its entire export book runs through long-standing relationships with a handful o...
Read the full report →capex, margin expansion, new product segment, geographic expansion
FY27 capacity expansion guided at 6,000 metric tons (reaching 52,500 total) with 70-75% utilization driven by capacity ramp-up and demand stabilization; bamboo initiative to add 3,000 CBM capacity in FY27
Guidance downgradedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for All Time Plastics Ltd. and 4,900+ companies.
5-day free pass. No card required.